Laurine Lagache | Oncology | Innovative Research Award

Published on by Cell Biologist

 

Innovative Research Award

Laurine Lagache
PRISM – Inserm U1192, France

Laurine Lagache
Affiliation PRISM – Inserm U1192
Country France
Scopus ID 59161941000
Documents 6
Citations 12
h-index 3
Subject Area Oncology
Event World Cell Biologist Awards
ORCID 0009-0000-4442-6642

Laurine Lagache is a researcher affiliated with PRISM – Inserm U1192 in France, with a research profile situated within the field of oncology. Her documented scholarly record comprises 6 documents, 12 citations, and an h-index of 3 according to the supplied Scopus profile information. [1] Her research context is relevant to contemporary cell biology and cancer research, disciplines in which cellular mechanisms, molecular interactions, disease progression, and therapeutic responses are closely interconnected. [2]

Abstract

The Innovative Research Award profile for Laurine Lagache presents a concise academic overview of a researcher working in oncology at PRISM – Inserm U1192, France. The profile is based on the supplied researcher identification and bibliometric information, including six indexed documents, twelve citations, and an h-index of three. [1] The research domain is positioned within the broader scientific landscape of oncology and cell biology, where investigation of cellular and molecular mechanisms contributes to understanding disease biology and developing improved approaches to diagnosis, prognosis, and treatment. [2]

Keywords

Laurine Lagache; Innovative Research Award; oncology; cell biology; cancer research; PRISM – Inserm U1192; biomedical research; molecular oncology; research impact; scientific innovation.

Introduction

Oncology is a multidisciplinary research field encompassing the biological mechanisms responsible for cancer development, progression, dissemination, and response to treatment. Modern cancer research increasingly integrates cellular biology, molecular biology, genetics, immunology, bioinformatics, and translational science to characterize disease processes at multiple levels. [2]

Research Profile

The supplied bibliometric profile identifies Laurine Lagache under Scopus Author ID 59161941000. The reported record contains 6 documents, 12 citations, and an h-index of 3. [1] These indicators provide quantitative information about indexed scholarly output and citation activity, but they should be interpreted in conjunction with publication quality, authorship contribution, research relevance, and the scientific context of the work.

Research Contributions

The available information establishes oncology as the principal subject area associated with the researcher profile. On this basis, the relevant contribution can be considered within the wider scientific objective of improving knowledge of cancer biology and its cellular and molecular foundations. However, the supplied data do not provide sufficient evidence to attribute a particular discovery, technique, therapeutic intervention, or clinical finding to Laurine LAGACHE. [4]

Publications

The supplied Scopus profile records 6 documents associated with the researcher identifier. [1] The available input does not provide individual publication titles, journals, publication years, author positions, or article-level DOI identifiers. Consequently, no specific publication is attributed to Laurine LAGACHE in this profile beyond the supplied bibliometric record.[3] [5]

Research Impact

The reported citation count of 12 and h-index of 3 indicate measurable scholarly citation activity within the supplied Scopus record. [1] Citation indicators can be useful for understanding the visibility of research outputs, although they do not independently establish the quality, originality, societal value, or practical significance of research. [3]

Award Suitability

Based on the supplied information, Laurine Lagache research profile is aligned with the scientific scope of an Innovative Research Award through its stated focus on oncology and its documented scholarly activity. The profile provides identifiable affiliation, research area, indexed documents, citations, h-index, and a persistent ORCID identifier, which together provide a basis for academic profile verification. [1] [3]

Conclusion

Laurine Lagache is presented as an oncology researcher affiliated with PRISM – Inserm U1192 in France. The supplied profile records 6 Scopus-indexed documents, 12 citations, and an h-index of 3, together with Scopus Author ID 59161941000 and ORCID 0009-0000-4442-6642. [1] [3]

References

  1. Elsevier. (n.d.). Scopus author details: Laurine LAGACHE, Author ID 59161941000. Scopus.
    https://www.scopus.com/pages/authors/59161941000
  2. L Lagache,D Simon, GS Horkovics-Kováts, et al. (2025). Subcellular-Resolution Molecular Pathology by Laser Ablation–Rapid Evaporative Ionization Mass Spectrometry.
    https://pubs.acs.org/ancham/article-abstract/97/32/17433/3622698
  3. L Lagache, J Salzet, I Fournier, M Salzet. (2026). Beyond Darwin: reactive heredity, burst-drift dynamics and eco‑evolutionary control of cancer.
    https://link.springer.com/article/10.1186/s12943-026-02683-w
  4. A Goossen, L Lagache, et al. (2026). A Universal Modular High-Plex MALDI Mass Spectrometry Imaging Platform.
    https://www.researchsquare.com/article/rs-9525563/v1
  5. L Lagache, M Salzet. (2026). Metastasis as a breakdown of the multicellular social contract.
    https://link.springer.com/article/10.1007/s10555-026-10352-z

Nikhil Gadewal | Biomarkers for Renal Cancer | Epigenetics in Cell Biology Award

Published on by Cell Biologist

Dr. Nikhil Gadewal | Biomarkers for Renal Cancer | Epigenetics in Cell Biology Award

Advanced Center for Treatment and Research in Cancer | India

Dr. Nikhil Gadewal is an accomplished scientist specializing in bioinformatics, molecular modeling, structure-based drug design, and integrative multi-omics analysis. His research portfolio includes 42 peer-reviewed publications spanning computational biology, cancer therapeutics, and systems-level data interpretation. A key focus of his work is the development and application of gene regulatory network analysis using multi-omics datasets to uncover molecular mechanisms underlying disease pathology, particularly in cancer. He has made significant contributions to structure-based drug design, identifying phytochemicals and small molecules with therapeutic potential for integrative cancer treatment strategies. His patented work on biomarkers and therapeutic targets for transformed epithelium in gingivo-buccal cancer reflects his expertise in translational cancer research and precision medicine. In addition to research, he actively contributes to capacity building by conducting workshops and training programs in next-generation sequencing (NGS) data analysis, molecular modeling, and molecular dynamics simulations. His work integrates computational approaches with biological insight to advance drug discovery, biomarker identification, and systems-level understanding of complex diseases.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Khare, S. P., Habib, F., Sharma, R., Gadewal, N., Gupta, S., & Galande, S. (2012). HISTome—A relational knowledgebase of human histone proteins and histone modifying enzymes. Nucleic Acids Research, 40(D1), D337–D342.

Chikhale, R., Thorat, S., Choudhary, R. K., Gadewal, N., & Khedekar, P. (2018). Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors. Bioorganic Chemistry, 77, 84–100.

Singh, S. V., Dakhole, A. N., Deogharkar, A., Kazi, S., Kshirsagar, R., Goel, A., … Gadewal, N. (2017). Restoration of miR-30a expression inhibits growth and tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition. Biochemical and Biophysical Research Communications, 491(4), 946–952.

Bejugam, P. R., Kuppili, R. R., Singh, N., Gadewal, N., Chaganti, L. K., Sastry, G. M., … (2013). Allosteric regulation of serine protease HtrA2 through a novel non-canonical substrate binding pocket. PLOS ONE, 8(2), e55416.

Tokala, R., Sana, S., Lakshmi, U. J., Sankarana, P., Sigalapalli, D. K., Gadewal, N., … (2020). Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity. Bioorganic Chemistry, 105, 104357.

Gadewal, N. S., & Zingde, S. M. (2011). Database and interaction network of genes involved in oral cancer: Version II. Bioinformation, 6(4), 169–175.